With an interest to evaluate SEMA5A expression between primary cancer and different metastatic sites, we utilized TMA with 21 cases of PC patients with primary tumor and either one, two or three metastatic sites like liver, diaphragm, and intestine. This evidence concerns the gene SEMA5A and cancer.